John Armitage - Egerton Capital (UK) LLP
Holding/activity history for Thermo Fisher Scientific (TMO)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | 3.03 | SEC | ||
| 2023 Q2 | 562,479 | 3.03 | Add 426.91% | 2.45 | $521.75 | $293,473,418 | SEC |
| 2023 Q1 | 106,751 | 0.78 | Buy | 0.78 | $576.37 | $61,528,074 | SEC |
| 2020 Q1 | 0 | 0.00 | Sell 100.00% | 2.29 | SEC | ||
| 2019 Q4 | 934,456 | 2.29 | Add 196.31% | 1.52 | $324.87 | $303,577,000 | SEC |
| 2019 Q3 | 315,359 | 0.70 | Reduce 7.25% | 0.06 | $291.27 | $91,855,000 | SEC |
| 2019 Q2 | 339,993 | 0.78 | Buy | 0.78 | $293.68 | $99,849,000 | SEC |